News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Mary Lou Smith

Articles by Mary Lou Smith

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer

Spotlighting the Top 10 FDA Oncology Approvals in 2025

Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML

Human Coaching Via Mobile App May Reduce Postgastrectomy Symptoms

What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting